2 unknown, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Marfan Syndrome: new trials by email Literature Review of Marfan Syndrome trials Research Report on Marfan Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Oxford Marfan Trial Irbesartan 150-300mg capsules daily for 6 months, Doxycycline 100-200mg capsules daily for 6 months, Doxycycline placebo capsules daily for 6 months - Marfan Syndrome | Phase 2 | Unknown | University of Oxford | 56 | 2013-10-01 | 2015-06-09 |
| Losartan Versus Atenolol for the Treatment of Marfan Syndrome Losartan, Atenolol - Marfan Syndrome | Phase 2 | Completed | University of British Columbia | 17 | 2008-01-01 | 2012-07-12 |
| A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome Losartan and Atenolol or Propranolol, Atenolol or Propranolol - Marfan Syndrome | Phase 2 | Unknown | National Taiwan University Hospital | 44 | 2007-02-01 | 2010-06-09 |
Abnormalities, Multiple (3) · Bone Diseases (3) · Bone Diseases, Developmental (3) · Cardiovascular Abnormalities (3) · Cardiovascular Diseases (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Connective Tissue Diseases (3) · Genetic Diseases, Inborn (3) · Heart Defects, Congenital (3) · Heart Diseases (3) · Musculoskeletal Diseases (3) · Skin and Connective Tissue Diseases (3)
Atenolol (2) · Losartan (2) · Doxycycline (1) · Irbesartan (1) · Propranolol (1)
National Taiwan University Hospital (1) · University of British Columbia (1) · University of Oxford (1)
Canada (1) · Taiwan (1) · United Kingdom (1)
Cornelius van Breemen, MD (1) · George Sandor, MD, FRCPC (1) · J Colin Forfar, BSc (hons), MA(Oxon), MD, PhD, (1) · James E. Potts, MD (1) · Mei-Hwan Wu (1)